The U.S. Food and Drug Administration is opening a new front in its efforts to reduce high drug prices by encouraging development of generic versions of hard-to-make medicines. Complex drugs and ...

In a promising move to tackle the escalating costs of prescription drugs, a new initiative known as the Limited-Competition Generic Market Priority Review Voucher (LCGM PRV) Program is making waves.

Attorneys general in most of the states, the District of Columbia and several territories have filed a lawsuit in federal court against more than two dozen generic drug manufacturers, alleging that ...

A new court ruling has the future use of skinny labels in question, but skinny-label generics have saved Medicare a lot of money over 5 years. Skinny labels, which carve out patent-protected ...

The FDA has approved several strengths of potassium chloride oral solutions as the first generic drugs to receive a Competitive Generic Therapy designation. The FDA has approved the first generic drug ...

The Food and Drug Administration on Tuesday published a list of brand name drugs without generic competition and implemented a policy to accelerate generic drug approvals. The actions represent the ...

To design an effective financing system for generic drug approvals, the FDA must balance the need to ensure sustainability with the goal of providing a level playing field for competition among firms ...

The amount of generic rivals available in relation to a brand name treatment can affect drug costs, according to a report in the Journal of the American Medical Association. Researchers identified all ...

Report from David Balto examines anticompetitive conduct that may delay the emergence of generic drugs and offers solutions. Thirty years ago former Supreme Court Chief Justice Warren Burger explained ...